Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.55 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.55 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.55 |
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 8/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 8/20 | 0.54 |
| ▸ | TPSAB1 | Q15661 | 8/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.53 |
| ▸ | CPB1 | P15086 | 1/20 | 0.52 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.52 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21293821 | 1.00 | TLR2 (0.55) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| SCHEMBL13722844 | 0.88 | ATM (0.51) | ITGB3ITGA2BCTSLCTSS | |
| SCHEMBL5692870 | 0.87 | ITGB3 (0.60) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| SCHEMBL9086439 | 0.87 | ITGB3 (0.60) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| SCHEMBL17382634 | 0.87 | TLR2 (0.62) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| Hydrochloric Acid SCHEMBL7284348 | 0.86 | ITGB3 (0.58) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| Hydrochloric Acid SCHEMBL7284342 | 0.86 | ITGB3 (0.58) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| SCHEMBL7761772 | 0.86 | PRSS1 (0.44) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| SCHEMBL7761868 | 0.86 | PRSS1 (0.44) | TLR2SIRT2SIRT1SIRT3PRSS1 | |
| SCHEMBL8953566 | 0.85 | SIRT2 (0.59) | TLR2SIRT2SIRT1SIRT3PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10973923-B2 | Site specific homogeneous with KSP inhibitors | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-04-13 | — | — | US | disclosed |
| US-20190262463-A1 | SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190262463-A1 | SITE SPECIFIC HOMOGENEOUS WITH KSP INHIBITORS | KIF5B, KIF15, KIF2C | TLR2 4861/4885SIRT2 3240/4885SIRT1 3442/4885 |
| US-10973923-B2 | Site specific homogeneous with KSP inhibitors | KIF5B, KIF15, KIF2C | TLR2 4861/4885SIRT2 3240/4885SIRT1 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.